Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.95 USD | +5.20% | +2.94% | +40.61% |
04-25 | Cardlytics Insider Sold Shares Worth $278,885, According to a Recent SEC Filing | MT |
04-09 | Cardlytics, Inc. Appoints Liane Hornsey to Its Board of Directors | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.
Strengths
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+40.61% | 624M | D+ | ||
+6.97% | 2,990B | C+ | ||
+5.80% | 83.1B | B | ||
+3.72% | 76.88B | B+ | ||
-15.18% | 52.88B | B+ | ||
+32.96% | 50.84B | D+ | ||
-25.56% | 46.09B | B- | ||
+17.43% | 41.3B | D+ | ||
+59.31% | 37.06B | D+ | ||
-10.36% | 24.61B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CDLX Stock
- Ratings Cardlytics, Inc.